Cytokinetics share price logo

Cytokinetics

NASDAQ: CYTK

Mid Cap

$65.64

-0.52

(-0.79%)

as on

Cytokinetics Stock Performance

as on September 30, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $64.38
    $66.52
    downward going graph

    1.92%

    Downside

    1.34%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $53.57
    $88.31
    downward going graph

    18.39%

    Downside

    34.54%

    Upside

    downward going graph

Cytokinetics share price movements today

Previous Close
$66.16
Open
$65.71
Volume
1.5M
Market Cap
$9.2B
Day's Low - High
$64.38 - $66.52
52 Week Low - High
$53.57 - $88.31

Cytokinetics Historical Returns

1 Month Return
-8.95 %
3 Month Return
-22.95 %
1 Year Return
+ 19.43 %
3 Year Return
+ 122.81 %
5 Year Return
+ 83.66 %

Cytokinetics Stock Fundamentals & Key Indicators

Check Cytokinetics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.2B

EPS (TTM)

-7.21

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-9.18

Industry PE ratio

-12.23

PEG Ratio

0.27

EBITDA

-818.6M

Revenue (TTM)

71.0M

Profit Margin

84.97%

Return On Equity TTM

163.98%

Cytokinetics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cytokinetics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$9.2B83.66%-9.1884.97%0.00%
StrongBuy$43.2B643.29%-22.770.00%0.00%
Neutral$78.8B-47.13%-24.72-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B24.01%17.9684.86%0.49%

Stock Returns calculator for Cytokinetics Stock including INR - Dollar returns

The Cytokinetics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cytokinetics investment value today

Current value as on today

₹1,29,229

Returns

₹29,229

(+29.23%)

Returns from Cytokinetics Stock

₹19,432 (+19.43%)

Dollar Impact

₹9,797 (+9.8%)

Analyst Recommendation on Cytokinetics Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.3076923076923% of analysts recommend a 'BUY' rating for Cytokinetics. Average target price of $109.9

Cytokinetics Share Price Target

Get share price movements and forecasts by analysts on Cytokinetics.

What analysts predicted

40.27%UPSIDE

Target Price

$109.9

Current Price

$65.64

Analyzed by

13 Analysts

High

$146

Target

$109.90

Low

$85

Cytokinetics target price $109.9, a slight upside of 40.27% compared to current price of $65.64. According to 13 analysts rating.

Indian Investors' Interest in Cytokinetics Stock

Search interest for Cytokinetics Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-57% versus previous 30 day period

Cytokinetics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
16
1
66
1
17
19
31
Gross Profit
-80
-79
-84
-76
-98
64
0
14
16
29
Operating Income
-126
-130
-140
-139
-155
-111
-166
-178
-183
-175
EBITDA
-115
-116
-135
-125
-136
-107
-277
-180
-169
-191
Interest Expense
17
24
22
22
22
24
26
30
33
34
Depreciation
2
2
2
2
2
2
2
2
3
7
Income Before Tax
-135
-143
-160
-150
-161
-134
-306
-183
-206
-198
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-135
-143
-160
-150
-161
-134
-306
-183
-206
-198
Net Profit Margin
-9668.86%
-31866.67%
-18174.73%
-453.13%
-6223.05%
96.58%
-38.38%
83.89%
87.64%
91.44%

Cytokinetics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
13
31
26
55
70
94
7
18
88
Gross Profit
-76
-57
-59
-41
-89
-146
-322
-320
77
Operating Income
-113
-88
-98
-93
-186
-324
-496
-536
-612
EBITDA
-108
-83
-93
-86
-176
-329
-456
-493
-775
Interest Expense
16
21
27
38
29
51
57
86
103
Depreciation
1
1
1
1
9
8
11
9
9
Income Before Tax
-127
-106
-121
-127
-215
-388
-526
-589
-784
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-127
-106
-121
-127
-215
-388
-526
-589
-784
Net Profit Margin
-575.46%
-182.96%
-220.55%
-73.66%
-127.09%
-154.59%
-4284.10%
-1737.22%
88.50%

Cytokinetics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-135
-143
-160
-150
-161
-134
-306
-183
-206
-198
Operating Cash Flow
-129
-99
-101
-65
-131
-128
-107
-142
-145
-159
Investing Cash Flow
32
-651
-45
110
105
52
-70
-71
145
-506
Financing Cash Flow
103
821
3
2
4
78
330
110
7
792
Change in Cash
6
70
-143
47
-21
2
152
-102
7
125

Cytokinetics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-127
-106
-121
-127
-215
-388
-526
-589
-784
Operating Cash Flow
-101
-101
-90
8
-142
-299
-414
-395
-510
Investing Cash Flow
-65
5
-74
-196
-147
-262
239
-553
16
Financing Cash Flow
225
13
159
234
319
516
221
930
524
Change in Cash
58
-82
-5
46
29
-45
46
-18
30

Global Institutional Holdings in Cytokinetics

Check out the Institutions with significant holdings in Cytokinetics.

Funds
Holdings
Vanguard
9.00%
iShares
8.96%
VANGUARD INDEX FUNDS
6.98%
T. ROWE PRICE CAPITAL APPRECIATION FUND, INC.
3.67%
SPDR
3.66%

Cytokinetics News & Key Events

  • img

    Today's Timeline - 28 August

    Fri, 07:26 PM

    -

    Cytokinetics reports positive Phase 3 results for aficamten, plans supplemental New Drug Application in Q4 2026.

Insights on Cytokinetics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CYTK has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 1.93M → 31.91M (in $), with an average increase of 45.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, CYTK stock has moved up by 122.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -206.03M → -198.76M (in $), with an average increase of 3.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 687.7% return, outperforming this stock by 668.3%

About Cytokinetics

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
OrganisationCytokinetics
Headquarters350 Oyster Point Boulevard, South San Francisco, CA, 94080, US
IndustryBiotechnology
CEORobert I. Blum

Key Management of Cytokinetics

Name

Title

Mr. Robert I. Blum

CEO, President & Director

Mr. Sung H. Lee

EVP & CFO

Dr. James H. Sabry M.D., Ph.D.

Co-Founder & Chairman of Scientific Advisory Board

Mr. Scott R. Jordan

Senior Vice President of Global Marketing & Commercial Strategy

Mr. Jeffrey J. Hessekiel J.D.

Executive VP, Chief Legal & Administrative Officer

Dr. Fady Ibraham Malik FACC, M.D., Ph.D.

Executive Vice President of Research & Development

Mr. Andrew M. Callos

Executive VP & Chief Commercial Officer

Dr. James A. Spudich Ph.D.

Co-Founder & Member of Scientific Advisory Board

Ms. Holly Laughlin

VP of Accounting & Corporate Controller

Mr. Steven M. Cook J.D.

Senior Vice President of Global Supply Chain Operations & Technical Operations

FAQs

What is Cytokinetics share price today?

Cytokinetics share price today is $65.64 as on at the close of the market. Cytokinetics share today touched a day high of $66.52 and a low of $64.38.

What is the 52 week high and 52 week low for Cytokinetics share?

Cytokinetics share touched a 52 week high of $88.31 on and a 52 week low of $53.57 on . Cytokinetics stock price today i.e. is closed at $65.64,which is 25.67% down from its 52 week high and 22.53% up from its 52 week low.

What is Cytokinetics's market capitalisation today?

Cytokinetics market capitalisation is $0.01T as on .

How to invest in Cytokinetics Stock (CYTK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cytokinetics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cytokinetics Stock (CYTK) from India?

Indian investors can start investing in Cytokinetics (CYTK) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Cytokinetics stock (as per the Rupee-Dollar exchange rate as on ). Based on Cytokinetics share’s latest price of $65.64 as on September 30, 2026 at 8:46 am IST, you will get 0.1523 shares of Cytokinetics. Learn more about fractional shares .

What are the returns that Cytokinetics has given to Indian investors in the last 5 years?

Cytokinetics stock has given 83.66% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?